Biomea Fusion, Inc. reports results for the quarter ended June 30 - Earnings Summary

Biomea Fusion

06/08/2026 01:25

Biomea Fusion, Inc. BMEA.OQ reported a quarterly adjusted loss of 12 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -51 cents.  The mean expectation of seven analysts for the quarter was for a loss of 22 cents per share. Wall Street expected results to range from -31 cents to -17 cents per share.
Reported revenue was zero​; analysts expected zero. 
Biomea Fusion, Inc.'s reported EPS for the quarter was a loss of 12 cents​.
The company reported a quarterly loss of $8.33 million.
Biomea Fusion, Inc. shares had fallen by 16.3% this quarter and lost 0.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 5.9% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Biomea Fusion, Inc. is $7.00, about 82% above its last closing price of $1.26
This summary was machine generated from LSEG data August 6 at 12:25 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.22
-0.12
Beat
Mar. 31 2026 
-0.24
-0.17
Beat
Dec. 31 2025 
-0.25
0.27
Beat
Sep. 30 2025 
-0.26
-0.27
Missed